Quantcast

Posts related to ‘ZGEN’

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Posted: September 9, 2010 at 1:57 pm

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months.  ...
Read Full Story »

Top Active Trader Alert Stocks (ARMH, AVII, BP, BRCD, CIEN, JASO, TUNE, ZRAN, TLB, QXM, ZGEN)

Posted: September 8, 2010 at 8:49 am

This Wednesday seems like there is a floodgate open of stocks on the move for active traders and day traders.  We are tracking key moves in shares of ARM Holdings ...
Read Full Story »

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Posted: May 27, 2009 at 1:34 pm

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down ...
Read Full Story »

ZymoGentics Backers File To Sell Stock (ZGEN, NVO)

Posted: November 25, 2008 at 4:53 pm

ZymoGenetics, Inc. (NASDAQ: ZGEN) has filed an SEC registration which would allow the company to sell up to $100 million of its common stock from time to time. What is ...
Read Full Story »

Top Analyst Upgrades & Downgrades (CEG, DENN, ODSY, ARO, D, EXEL, JNJ, VOCS, ZGEN)

Posted: October 29, 2008 at 7:08 am

These are some of the other non-tech analyst upgrades and downgrades from Wall Street firms this Wednesday morning:Constellation Energy (CEG) Raised to Buy at Jefferies.Denny’s (DENN) Raised to Buy at ...
Read Full Story »

Select Positive ASCO Data (ARRY, AZN, LLY, DNA, GSK, ONXX, PFE, ZGEN)

Posted: May 16, 2008 at 7:26 am

Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to publish all of the findings to the public at once.  ...
Read Full Story »

Pre-Market Stock News (June 19, 2007)

Posted: June 19, 2007 at 7:11 am

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: ...
Read Full Story »

Earlybird Analyst Calls (June 14, 2007)

Posted: June 14, 2007 at 6:29 am

ACL started as Buy at Jefferies.AMGN started as Mkt Perform at Rodman & Renshaw.B started as Outperform at CIBC.CBB started as Buy at UBS.CHE started as Buy at Jefferies.CTL raised ...
Read Full Story »